Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European Global Times.
Press releases published on March 25, 2025

Allegro’s injectable osteoarthritis treatment generates positive safety results in preclinical studies
Microparticle hydrogel shows clean systemic toxicity profile over 4 weeks and 13 weeks Treatment designed to restore shock-absorbing capacities of joints in osteoarthritis Allegro plans to start pivotal clinical trials in osteoarthritis patients in 2025 …

منصة السفر الرائدة WINGIE تكشف عن أبرز الوجهات لعطلة عيد الفطر 2025
بي، الإمارات العربية المتحدة والرياض، المملكة العربية السعودية،, March 25, 2025 (GLOBE NEWSWIRE) -- مع اقتراب عيد الفطر، يتزايد الطلب على السفر في منطقة الشرق الأوسط وشمال أفريقيا. وقد حددت منصة WINGIE، الرائدة في مجال حجوزات السفر عبر الإنترنت في المنطقة، …

Leading Travel Marketplace WINGIE Reveals Key Destinations for the 2025 Eid al-Fitr Holiday
DUBAI, United Arab Emirates, and RIYADH, Saudi Arabia, March 25, 2025 (GLOBE NEWSWIRE) -- As Eid al-Fitr approaches, travel demand is increasing across the MENA region. WINGIE, the leading online travel marketplace in MENA, has identified key destinations …

Progress on share buyback programme
Progress on share buyback programme ING announced today that, as part of our €2.0 billion share buyback programme announced on 31 October 2024, in total 2,766,772 shares were repurchased during the week of 17 March 2025 up to and including 21 March 2025. …

Shell accelerates strategy to deliver more value with less emissions
March 25, 2025 – Shell (LON/NYSE: SHEL, AMST: SHELL) will today present to investors at its Capital Markets Day 2025 the next steps in the execution of its strategy. Shell is strengthening its commitment to value creation and maintaining its focus on …

Technip Energies convoque son assemblée générale annuelle 2025
Technip Energies (PARIS:TE), une entreprise de technologies et d’ingénierie de premier plan dans les infrastructures énergétiques et de décarbonation, annonce aujourd'hui la publication de l'avis de convocation à son assemblée générale annuelle qui se …

Technip Energies convenes its 2025 annual general meeting
Technip Energies (PARIS:TE), a global technology …

The Royal Office of H.H. Sheikh Ahmed Bin Faisal Al-Qassimi and ACET ($ACT) Drive Blockchain Payment Innovation in UAE’s $3.9 Billion USD Initiative
DUBAI, United Arab Emirates, March 25, 2025 (GLOBE NEWSWIRE) -- ACET ($ACT), a pioneering blockchain-powered decentralized finance (DeFi) platform, has entered into a Memorandum of Understanding (MoU) with the Royal Office of His Highness Sheikh Ahmed Bin …

Valneva Announces Filing of 2024 Universal Registration Document and US Form 20-F
Saint-Herblain (France), March 25, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announced today the filing, on March 24, 2025, of its 2024 Universal Registration Document (URD) with the French Financial Markets …

Valneva annonce le dépôt de son Document d’Enregistrement Universel 2024 et de son rapport annuel américain « Form 20-F »
Saint-Herblain (France), 25 mars 2025 – Valneva SE (Nasdaq : VALN; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd’hui le dépôt, le 24 mars 2025, de son Document d’enregistrement universel 2024 auprès de l’Autorité des …

ABC arbitrage: 2024 Results
Press release - Paris, March 25, 2025 07:00AM ABC arbitrage 2024 Results¹: €26.8 m (+63%) ROE 2024: 16.4% | Per share distribution 2024: €0.34 The Board of Directors of ABC arbitrage, presided by the Chairman Dominique Ceolin, met on March 20, 2025 to …

ABC arbitrage : Résultat consolidé 2024
Communiqué de presse - Paris le 25 mars 2025, 07h00 ABC arbitrage Résultat consolidé 20241 : 26,8 M€ (+63%) ROE 2024 : 16,4% | Distribution par action 2024 : 0,34 € Le conseil d’administration de la société ABC arbitrage s’est réuni le 20 mars 2025, …

Press Release: Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis
Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis If approved, tolebrutinib would be the first and only brain-penetrant BTK inhibitor to both treat non-relapsing secondary progressive multiple …

Communiqué de presse : Examen prioritaire accordé aux États-Unis à la soumission réglementaire relative au tolebrutinib pour le traitement de la sclérose en plaques
Examen prioritaire accordé aux États-Unis à la soumission réglementaire relative au tolebrutinib pour le traitement de la sclérose en plaques S’il est approuvé, le tolebrutinib sera le premier et le seul inhibiteur de la BTK à pénétration cérébrale pour le …

NMD Pharma presents preclinical data highlighting increased innervation of skeletal muscle with ClC-1 ion channel inhibition treatment in neuromuscular disease model
Company presented clinical and preclinical data at the MDA Conference last week in Dallas, Texas Oral presentation included data from MuSK-MG rat model depicting increases in muscle function and improvements in the structural integrity of the neuromuscular …

Einladung zur Ascom Generalversammlung 2025
Sehr geehrte Damen und Herren Anbei finden Sie die Einladung zur Ascom Generalversammlung 2025. Diese findet am Mittwoch, 16. April 2025, 14.00 Uhr, statt. Der Veranstaltungsort ist das Theater Casino Zug, Artherstrasse 2-4, 6300 Zug. Weitere Details zur …

Invitation to Ascom Annual General Meeting 2025
Ladies and Gentlemen Please find enclosed the invitation to the Ascom Annual General Meeting 2025. This will take place on Wednesday, April 16, 2025, at 2 p.m. The venue is the Theater Casino Zug, Artherstrasse 2-4, 6300 Zug. Further details on the meeting …

BSTR Miner announced the upgrade of its “Stress-Resistant Mining Plan” to provide miners with a low-risk, highly flexible solution to meet market challenges.
London, UK, March 24, 2025 (GLOBE NEWSWIRE) -- [Industry background: mining costs soar, individual miners are under pressure] According to Bitbo data, the difficulty of Bitcoin network mining reached a historical peak of **150 T** on March 25, an increase …

Nxera Pharma’s Partner Tempero Bio Initiates Phase 2 Trial with TMP-301 for Alcohol Use Disorder
Tokyo, Japan and Cambridge, UK, 25 March 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) announces that its partner Tempero Bio, Inc. has initiated a Phase 2 trial of TMP-301, a potent, selective and orally available mGluR5 negative …